Emad Rizk, M.D., is the Chairman, President and Chief Executive Officer of Cotiviti. He brings a 30-year, well-documented track record of delivering improved quality and financial performance to healthcare organizations through forward-thinking leadership, business acumen, and clinical expertise.
With his extensive experience working with payers, hospital systems, government, physicians, and pharmaceutical companies, Dr. Rizk has brought focus and rigor to Cotiviti’s healthcare analytics and technology offerings, while positioning the organization for significant growth. Notably, under Dr. Rizk’s leadership, when he was CEO of Verscend Technologies, he completed the $4.9 billion acquisition of Cotiviti Holdings, the largest payer analytics acquisition of 2018.
Prior to Cotiviti, Dr. Rizk served as President and Chief Executive Officer of Accretive Health (now R1 RCM), and as a member of its board of directors, where he completed the restatement, restructuring, and repositioning of the company’s offerings and led its profitability to quadruple during his tenure. Prior to Accretive Health, Dr. Rizk was President of McKesson Health Solutions, where he grew the company’s healthcare payer business to one of the largest and most significant leaders in healthcare analytics. Before joining McKesson, Dr. Rizk served as Senior Partner and Global Director for Deloitte Consulting, leading the company’s medical cost and quality management practice across all segments.
Dr. Rizk serves on boards around the country and serves on the Healthcare Leadership Council— a coalition of chief executives across the entire industry that works to bring affordable and high-quality healthcare to all Americans through the growth of health information technology and reforming payment. He is also a Senior Scholar at Jefferson Medical College and an editorial board member of Managed Care magazine. Dr. Rizk has also previously held advisory roles with Intarcia Therapeutics, Accuray, the Care Continuum Alliance, University of Miami, University of North Texas, the National Clinical Advisory Board, and the National Quality Review Board.
Well recognized by the industry, Dr. Rizk has been named by Modern Healthcare numerous times as one of the “50 Most Influential Physician Executives in the United States” as well as the “Top 100 Most Powerful People in Healthcare.” Additionally, Managed Healthcare Executive named him to its “Top 25 Leaders in Disease Management.” He has lectured at Wharton, Harvard, MIT, Columbia, and the Kellogg School of Management. Dr. Rizk’s is the author of “The New Era of Healthcare: Practical Strategies for Providers and Payers.” His work has also been widely published in healthcare business publications and medical journals.